Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M342Revenue (TTM) $M96.5Net Margin (%)-81.8Altman Z-Score-6.0
Enterprise Value $M303EPS (TTM) $-0.9Operating Margin %-78.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-81.8Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %-24.0Current Ratio2.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-54.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-87.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M93.6ROIC % (ttm)-319.1Gross Margin Increase y-yN

Gurus Latest Trades with PACB

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

PACB is held by these investors:



PACB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Phillips James MichaelSVP, Research & Development 2016-10-28Sell20,000$8.44-56.64view
Phillips James MichaelSVP, Research & Development 2016-07-29Sell20,000$8.45-56.69view
Phillips James MichaelSVP, Research & Development 2016-04-25Sell20,000$10.29-64.43view
Phillips James MichaelSVP, Research & Development 2015-08-07Sell16,689$4.61-20.61view
Phillips James MichaelSVP, Research & Development 2015-03-02Buy1,877$4.91-25.46view
CORCORAN KEVIN PSVP, Market Development 2015-03-02Buy2,816$4.91-25.46view
Dow Brian BVP and PAO 2015-03-02Buy2,503$4.91-25.46view
Ericson William W.Director 2014-08-19Buy39,299$5.14-28.79view
Ericson William W.Director 2014-08-18Buy135,155$5.09-28.09view
Ericson William W.Director 2014-08-14Buy77,822$5-26.8view

Quarterly/Annual Reports about PACB:

News about PACB:

Articles On GuruFocus.com
Pacific Biosciences of California, Inc. Announces First Quarter 2017 Financial Results Apr 26 2017 
Pacific Biosciences of California, Inc. First Quarter 2017 Financial Results Call Apr 18 2017 
Meridian Funds Comments on Pacific Biosciences of California Inc. Mar 08 2016 
Weekly CEO Buys Highlight: CLR, CLMS, OPK, PACB, GAIN Dec 16 2013 
Weekly CEO Buys Highlight: OPK, PACB, CUBI, ARCP, RLYP Nov 25 2013 
Weekly CEO Buys Highlight: PHII, TUES, PACB, IPHI, WMC Dec 09 2012 
Weekly CEO Buys Highlight: PACB, AKS, EPIQ, GGS, TPGI Dec 02 2012 
Weekly CEO Buys Highlight: FFIN, STEC, MPO, PACB, TPGI Nov 25 2012 
Weekly CEO Buys Highlight: SUNS, PACB, GM, NPO, DGX Aug 11 2012 

More From Other Websites
ETFs with exposure to Pacific Biosciences of California, Inc. : May 22, 2017 May 22 2017
Recent Publications Demonstrate Rapid Adoption of SMRT Sequencing for Plant and Animal Transcriptome... May 22 2017
Pacific Biosciences of California, Inc. :PACB-US: Earnings Analysis: Q1, 2017 By the Numbers : May... May 09 2017
This Is the Big Reason Behind Pacific Biosciences of California, Inc.'s 24% Tumble in April May 03 2017
Edited Transcript of PACB earnings conference call or presentation 26-Apr-17 8:30pm GMT Apr 28 2017
Today's Research Reports on Biotech Stocks to Watch: Pacific Biosciences of California and BioMarin... Apr 28 2017
Pacific Biosciences of California Reports Q1 Loss Due to Higher Costs Apr 27 2017
Here's Why Pacific Biosciences of California Is Sliding Today Apr 27 2017
Biotech Movers: Pacific Biosciences Falls After Net Loss Spikes Apr 27 2017
Pacific Biosciences (PACB) Q1 Loss Wider than Estimated Apr 27 2017
Pacific Biosciences reports 1Q loss Apr 26 2017
Pacific Biosciences of California, Inc. Announces First Quarter 2017 Financial Results Apr 26 2017
Pacific Biosciences of California, Inc. – Value Analysis (NASDAQ:PACB) : April 25, 2017 Apr 25 2017
Pacific Biosciences of California, Inc. breached its 50 day moving average in a Bullish Manner :... Apr 24 2017
The Top Gene-Sequencing Stock to Buy in 2017 Apr 20 2017
Pacific Biosciences of California, Inc. First Quarter 2017 Financial Results Call Apr 18 2017
Pacific Biosciences (PACB): What Awaits in Q1 Earnings? Apr 17 2017
3 Big Reasons to Be Bullish on Biotech Stocks Apr 16 2017
Pacific Biosciences of California, Inc. breached its 50 day moving average in a Bearish Manner :... Apr 06 2017
Pacific Biosciences of California and Nymox Pharmaceutical Move Up On Bullish Product Environments Mar 30 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)